- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Fatty Liver in New Zealand
Total 1712 results
-
Hoffmann-La RocheCompletedHepatitis C, ChronicNew Zealand, Australia
-
Gilead SciencesCompletedChronic Hepatitis BUnited States, New Zealand
-
Arena PharmaceuticalsTerminatedPrimary Biliary CholangitisUnited States, Australia, New Zealand
-
Eiger BioPharmaceuticalsCompletedHepatitis D, ChronicIsrael, New Zealand, Pakistan
-
Hoffmann-La RocheTerminatedHepatitis B, ChronicHong Kong, Taiwan, New Zealand
-
Gilead SciencesCompletedHepatitis C | Cirrhosis | Portal Hypertension | With or Without Liver DecompensationUnited States, Spain, New Zealand, Australia, France
-
Concord Repatriation General HospitalRecruitingHCC | Hepatocellular CarcinomaAustralia, New Zealand
-
Arbutus Biopharma CorporationCompletedHepatitis B, ChronicAustralia, New Zealand
-
Syneos HealthF-star Therapeutics, Inc.CompletedHepatitis C InfectionAustralia, New Zealand
-
Kirby InstituteCompletedDAA-based Therapy for Recently Acquired Hepatitis C II (DAA = Directly Acting Antiviral) (DARE-C II)Hepatitis CAustralia, New Zealand
-
Beth Israel Medical CenterTerminatedFatty Liver | Chronic Hepatitis C InfectionUnited States
-
Macfarlane Burnet Institute for Medical Research...St Vincent's Hospital MelbourneCompletedHepatitis CAustralia, New Zealand
-
National Medical Research Council (NMRC), SingaporeCompletedLiver CancerSingapore, Bangladesh, Thailand, Vietnam, Philippines, Indonesia, Korea, Republic of, Myanmar, New Zealand, Taiwan
-
Columbia UniversityAlmond Board of CaliforniaCompletedObesity | Overweight | Fatty Liver | Metabolic Syndrome XUnited States
-
Gilead SciencesCompletedHCV InfectionUnited States, Germany, New Zealand
-
Yale UniversityRecruitingAlcohol-Induced Disorders | Chemical and Drug Induced Liver Injury | Acute Alcoholic Hepatitis | Steatohepatitis Caused by Ingestible AlcoholUnited States
-
NGM Biopharmaceuticals, IncNGM Biopharmaceuticals Australia Pty LtdCompletedPrimary Biliary CirrhosisUnited States, Australia, New Zealand
-
Boehringer IngelheimZealand PharmaCompletedLiver Diseases | Healthy | ObesityGermany, United States, Hungary, New Zealand, Slovakia, Poland
-
Hoffmann-La RocheTempest Therapeutics; Adagene Inc; Immune-Onc Therapeutics; NiKang Therapeutics...RecruitingAdvanced Liver CancersKorea, Republic of, Taiwan, United States, Israel, China, France, New Zealand
-
Gilead SciencesCompletedHepatitis B VirusUnited States, Germany, New Zealand
-
Aligos TherapeuticsTerminatedChronic Hepatitis BNew Zealand, Bulgaria, Moldova, Republic of, Romania
-
Alios Biopharma Inc.Vertex Pharmaceuticals IncorporatedTerminatedHepatitis C, ChronicAustralia, New Zealand
-
Gilead SciencesCompletedHCV InfectionUnited States, New Zealand, Germany
-
Arrowhead PharmaceuticalsCompletedHepatitis BAustralia, Hong Kong, New Zealand
-
Hoffmann-La RocheCompletedHepatitis B, ChronicTaiwan, United States, New Zealand, Singapore
-
Hoffmann-La RocheCompletedHepatitis B, ChronicTaiwan, United States, New Zealand, Singapore
-
Gilead SciencesCompletedHepatitis C VirusUnited States, New Zealand
-
Janssen Research & Development, LLCTerminated
-
AlexionCompletedWilson DiseaseUnited States, New Zealand, United Kingdom
-
Cubist Pharmaceuticals LLCTerminatedLiver Transplantation | Hepatitis BNew Zealand, United States, Israel, United Kingdom, France, Germany, Spain
-
Eli Lilly and CompanyRecruitingHepatic Insufficiency | HealthyUnited States
-
Kirby InstituteAbbVieCompletedHepatitis C, AcuteUnited Kingdom, Australia, New Zealand
-
Govind Ballabh Pant HospitalUnknownAcute on Chronic Liver FailureIndia
-
Baxalta now part of ShireCompletedAlpha 1-Antitrypsin DeficiencyNew Zealand, Australia
-
Trek Therapeutics, PBCCompletedChronic Hepatitis C | Hepatitis C Genotype 1 | Hepatitis C (HCV) | Hepatitis C Viral InfectionUnited States, New Zealand
-
Institute of Liver and Biliary Sciences, IndiaNot yet recruitingAcute on Chronic Liver FailureIndia
-
Institute of Liver and Biliary Sciences, IndiaCompletedAcute Liver FailureIndia
-
Institute of Liver and Biliary Sciences, IndiaRecruitingAcute on Chronic Liver FailureIndia
-
Institute of Liver and Biliary Sciences, IndiaUnknownAcute-On-Chronic Liver FailureIndia
-
Institute of Liver and Biliary Sciences, IndiaCompletedAcute on Chronic Liver FailureIndia
-
Institute of Liver and Biliary Sciences, IndiaCompletedAcute Liver Failure | Acute on Chronic Liver FailureIndia
-
Institute of Liver and Biliary Sciences, IndiaRecruitingLiver Cirrhosis | Acute-On-Chronic Liver Failure | Acute Liver FailureIndia
-
Institute of Liver and Biliary Sciences, IndiaNot yet recruitingAcute on Chronic Liver FailureIndia
-
Institute of Liver and Biliary Sciences, IndiaUnknown
-
Institute of Liver and Biliary Sciences, IndiaUnknownAcute-On-Chronic Liver FailureIndia
-
Institute of Liver and Biliary Sciences, IndiaWithdrawnAcute-On-Chronic Liver FailureIndia
-
Institute of Liver and Biliary Sciences, IndiaTerminatedAcute on Chronic Liver FailureIndia
-
GlaxoSmithKlineTerminatedLiver Diseases | HIV Infection | Thrombocytopenia | Hepatitis C Virus | HBV | NASH - Nonalcoholic Steatohepatitis | Human Immunodeficiency Virus | Chronic Liver Disease | HCV | Non-alcoholic Steatohepatitis | Hepatitis B VirusUnited States, Spain, Taiwan, Italy, Belgium, France, Korea, Republic of, Canada, Russian Federation, Pakistan, Poland, India, Argentina
-
Institute of Liver and Biliary Sciences, IndiaNot yet recruitingAcute-On-Chronic Liver FailureIndia
-
Institute of Liver and Biliary Sciences, IndiaNot yet recruitingAcute-On-Chronic Liver FailureIndia